IgA nephropathy trials in Colombia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  Where

  Barranquilla, Medellín

  Age

  2 years to 18 years

  People

  28 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07498335
• Phase 3Taking people
  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Where

  Barranquilla, Bogotá, Cali, Zipaquirá

  Age

  18 years and over

  People

  454 worldwide

  Run by

  Biogen

  See details and how to joinNCT06935357 · EU 2024-519345-30-00
• Phase 3Taking people
  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Where

  Barranquilla, Medellín

  Age

  18 years to 100 years

  People

  540 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04557462 · EU 2023-508690-92-00